Literature DB >> 2665013

Clinical aspects of African viral hemorrhagic fevers.

J H Gear1.   

Abstract

Three hemorrhagic fevers occur in southern Africa: Rift Valley fever, Marburg virus disease, and Crimean-Congo hemorrhagic fever. The patient's history of travel in Africa, visits to rural areas, contact with sick animals or their carcasses, or contact with a tick-infested environment or tick bites is important. Rift Valley fever is characterized by an incubation period of approximately 3 or 4 days, sudden onset of fever with a biphasic course, and signs and symptoms of liver and kidney disorder. The commonest complication is retinitis with a central scotoma. Severe cases may develop a hemorrhagic state, which may be fatal. Marburg virus disease was studied in two Australian students after a tour of Rhodesia (now Zimbabwe) and in a nurse who cared for them. The incubation period of approximately 7 days is followed by sudden onset of fever (typically lasting 7 days) and the appearance of a maculopapular petechial rash on the 5th day. A hemorrhagic state develops about the same time and may be fatal. Crimean-Congo hemorrhagic fever is widespread in South Africa; it may be transmitted by tick bite of the species Hyalomma, by contact with the tissues of animals, or by contact with infected patients.

Entities:  

Mesh:

Year:  1989        PMID: 2665013     DOI: 10.1093/clinids/11.supplement_4.s777

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  8 in total

Review 1.  A Forgotten Episode of Marburg Virus Disease: Belgrade, Yugoslavia, 1967.

Authors:  Elizabeta S Ristanović; Nenad S Kokoškov; Ian Crozier; Jens H Kuhn; Ana S Gligić
Journal:  Microbiol Mol Biol Rev       Date:  2020-05-13       Impact factor: 11.056

2.  Respiratory Marburg virus infection in guinea pigs.

Authors:  E Ryabchikova; L Strelets; L Kolesnikova; O Pyankov; A Sergeev
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

3.  Monoclonal antibodies combined with adenovirus-vectored interferon significantly extend the treatment window in Ebola virus-infected guinea pigs.

Authors:  Xiangguo Qiu; Gary Wong; Lisa Fernando; Jane Ennis; Jeffrey D Turner; Judie B Alimonti; Xiaojian Yao; Gary P Kobinger
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

Review 4.  Syndromes with renal failure and shock.

Authors:  M Levin
Journal:  Pediatr Nephrol       Date:  1994-04       Impact factor: 3.714

Review 5.  Ebola Virus Disease (The Killer Virus): Another Threat to Humans and Bioterrorism: Brief Review and Recent Updates.

Authors:  Deepak Passi; Sarang Sharma; Shubha Ranjan Dutta; Pooja Dudeja; Vivek Sharma
Journal:  J Clin Diagn Res       Date:  2015-06-01

6.  Molecular epidemiology of Rift Valley fever virus.

Authors:  Antoinette A Grobbelaar; Jacqueline Weyer; Patricia A Leman; Alan Kemp; Janusz T Paweska; Robert Swanepoel
Journal:  Emerg Infect Dis       Date:  2011-12       Impact factor: 6.883

Review 7.  Viral infections in workers in hospital and research laboratory settings: a comparative review of infection modes and respective biosafety aspects.

Authors:  Pedro B S Pedrosa; Telma A O Cardoso
Journal:  Int J Infect Dis       Date:  2011-04-14       Impact factor: 3.623

Review 8.  Infection risks following accidental exposure to blood or body fluids in health care workers: a review of pathogens transmitted in published cases.

Authors:  Arnaud Tarantola; Dominique Abiteboul; Anne Rachline
Journal:  Am J Infect Control       Date:  2006-08       Impact factor: 2.918

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.